Verition Fund Management Portfolio holdings
AUM
$17.4B
1-Year Return
15.18%
This Quarter Return
+8.18%
1 Year Return
+15.18%
3 Year Return
+52.88%
5 Year Return
+61.62%
10 Year Return
+138.21%
AUM
$17.4B
AUM Growth
+$16.4M
(+0.09%)
Cap. Flow
-$2.3B
Cap. Flow
% of AUM
-13.26%
Top 10 Holdings %
Top 10 Hldgs %
8.75%
Holding
3,187
New
547
Increased
1,202
Reduced
1,020
Closed
311
Top Buys
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$342M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$80.6M |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$71.2M |
| 4 |
Carlyle Group
CG
|
+$69.9M |
| 5 |
SPDR S&P 500 ETF Trust
SPY
|
+$67.8M |
Top Sells
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.17B |
| 2 |
NVIDIA
NVDA
|
+$628M |
| 3 |
Amazon
AMZN
|
+$483M |
| 4 |
Microsoft
MSFT
|
+$272M |
| 5 |
Ameren
AEE
|
+$67.1M |
Sector Composition
| 1 | Financials | 16.86% |
| 2 | Consumer Discretionary | 14.15% |
| 3 | Technology | 13.21% |
| 4 | Industrials | 10.88% |
| 5 | Consumer Staples | 6.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1801
J&J Snack Foods
JJSF
$2.02B
| $1.02M | ﹤0.01% |
8,999
-1,115
| -11% | -$126K |
|
|
DMAA
1802
Drugs Made In America Acquisition Corp. Ordinary Shares
DMAA
$345M
| $1.02M | ﹤0.01% |
+100,000
| New | +$1.02M |
|
|
MRX
1803
Marex Group
MRX
$2.43B
| $1.02M | ﹤0.01% |
25,829
+17,089
| +196% | +$675K |
|
|
RAC
1804
Rithm Acquisition Corp.
RAC
$300M
| $1.02M | ﹤0.01% |
+100,000
| New | +$1.02M |
|
1805
Intellia Therapeutics
NTLA
$1.23B
| $1.02M | ﹤0.01% |
108,605
-162,829
| -60% | -$1.53M |
|
1806
Xencor
XNCR
$613M
| $1.01M | ﹤0.01% |
128,949
+100,917
| +360% | +$793K |
|
1807
Openlane
KAR
$3.07B
| $1.01M | ﹤0.01% |
41,452
-27,573
| -40% | -$674K |
|
1808
MGP Ingredients
MGPI
$596M
| $1.01M | ﹤0.01% |
33,791
-1,078
| -3% | -$32.3K |
|
1809
Ziff Davis
ZD
$1.5B
| $1.01M | ﹤0.01% |
33,445
+23,835
| +248% | +$721K |
|
1810
Photronics
PLAB
$1.33B
| $1.01M | ﹤0.01% |
53,764
-32,428
| -38% | -$611K |
|
|
CMRC
1811
Commerce.com, Inc. Series 1 Common Stock
CMRC
$370M
| $1.01M | ﹤0.01% |
202,364
+103,301
| +104% | +$517K |
|
1812
West Fraser Timber
WFG
$5.96B
| $1.01M | ﹤0.01% |
13,800
+8,569
| +164% | +$628K |
|
1813
Amcor
AMCR
$19.1B
| $1.01M | ﹤0.01% |
109,710
-192,108
| -64% | -$1.77M |
|
1814
WNS Holdings
WNS
$3.25B
| $1.01M | ﹤0.01% |
+15,900
| New | +$1.01M |
|
1815
Relay Therapeutics
RLAY
$688M
| $1.01M | ﹤0.01% |
290,599
+151,355
| +109% | +$524K |
|
1816
Scotiabank
BNS
$78.7B
| $1M | ﹤0.01% |
18,125
+1,732
| +11% | +$95.7K |
|
|
RAAQ
1817
Real Asset Acquisition Corp. Class A Ordinary Share
RAAQ
| $1M | ﹤0.01% |
+98,533
| New | +$1M |
|
|
PELI
1818
Pelican Acquisition Corporation Ordinary Shares
PELI
$120M
| $1M | ﹤0.01% |
+100,000
| New | +$1M |
|
1819
Central Garden & Pet Class A
CENTA
$2.03B
| $999K | ﹤0.01% |
31,919
-5,630
| -15% | -$176K |
|
1820
Bank of Hawaii
BOH
$2.7B
| $997K | ﹤0.01% |
14,771
-3,845
| -21% | -$260K |
|
1821
Lakeland Financial Corp
LKFN
$1.66B
| $995K | ﹤0.01% |
16,189
+9,233
| +133% | +$567K |
|
1822
TG Therapeutics
TGTX
$5.1B
| $994K | ﹤0.01% |
27,631
-2,514
| -8% | -$90.5K |
|
1823
Horace Mann Educators
HMN
$1.94B
| $988K | ﹤0.01% |
22,985
+9,983
| +77% | +$429K |
|
1824
Trinity Industries
TRN
$2.28B
| $987K | ﹤0.01% |
36,541
-17,592
| -32% | -$475K |
|
1825
WELLS FARGO 7.5% NON CUMV PERP CONV
WFC.PRL
$4.99B
| – | – |
0
| – | – |
|